Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Baran Chemical & Pharmaceutical is a leading pharmaceutical company based in Iran that specializes in the development and production of high-tech Active Pharmaceutical Ingredients (APIs) and finished dosage forms. The company is particularly recognized for its expertise in high-potency APIs (HPAPIs), utilizing advanced containment technologies to manufacture complex molecules for oncology, neurology, and cardiovascular diseases. Their state-of-the-art facilities in Tehran and the Eshtehard Industrial City adhere to international GMP standards, enabling the production of critical medications such as fingolimod and various tyrosine kinase inhibitors. Baran plays a vital role in the regional healthcare supply chain by providing affordable access to specialized, high-cost generic drugs. The company continues to expand its portfolio through robust research and development focused on difficult-to-synthesize chemical entities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Baran Chemical.